These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2901958)

  • 1. Receptor-mediated inotropic drugs.
    van Zwieten PA
    Eur Heart J; 1988 Jun; 9 Suppl H():85-90. PubMed ID: 2901958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dopexamine: a new dopaminergic agonist].
    Perrin G; Papazian L; Martin C
    Ann Fr Anesth Reanim; 1993; 12(3):308-20. PubMed ID: 7902685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular pharmacology of adrenergic and dopaminergic receptors: therapeutic significance in congestive heart failure.
    Lokhandwala MF; Hegde SS
    Am J Med; 1991 May; 90(5B):2S-9S. PubMed ID: 1675549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of new inotropic agents in the treatment of acute cardiac failure].
    Dhainaut JF
    Ann Fr Anesth Reanim; 1988; 7(2):97-104. PubMed ID: 2896479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New dopamine agonists in cardiovascular therapy].
    Girbes AR; Van Veldhuisen DJ; Smit AJ
    Presse Med; 1992 Aug 29-Sep 5; 21(27):1287-91. PubMed ID: 1359528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopexamine in congestive heart failure: how do the pharmacological activities translate into the clinical situation?
    Meinertz T; Drexler H; Just H
    Basic Res Cardiol; 1989; 84 Suppl 1():177-86. PubMed ID: 2573340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some new positive inotropic agents.
    Andersson KE
    Acta Med Scand Suppl; 1986; 707():65-73. PubMed ID: 2874692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dopaminergic agents on cardiac and renal function in normal man and in patients with congestive heart failure.
    van Veldhuisen DJ; Girbes AR; de Graeff PA; Lie KI
    Int J Cardiol; 1992 Dec; 37(3):293-300. PubMed ID: 1361484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical use of inotropes in cardiac failure: dopamine, dobutamine, prenalterol and pirbuterol.
    Rae AP; Tweddel AC; Hutton I
    Herz; 1983 Feb; 8(1):23-33. PubMed ID: 6832690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Positive inotropic agents. Generalities and classification].
    Vahanian A; Le Potier J; Sergent J; Michel PL; Acar J
    Ann Med Interne (Paris); 1985; 136(3):242-6. PubMed ID: 2862822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased contribution of alpha 1- vs. beta-adrenoceptor-mediated inotropic response in rats with congestive heart failure.
    Sjaastad I; Schiander I; Sjetnan A; Qvigstad E; Bøkenes J; Sandnes D; Osnes JB; Sejersted OM; Skomedal T
    Acta Physiol Scand; 2003 Apr; 177(4):449-58. PubMed ID: 12648162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic heart failure: effect and evaluation of therapy with positive inotropic substances].
    Thormann J; Kramer W; Dieterich HA
    Herz; 1990 Jun; 15(3):190-201. PubMed ID: 2198220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical management of chronic heart failure: inotropic, vasodilator, or inodilator drugs?
    Lang R
    Am Heart J; 1990 Dec; 120(6 Pt 2):1558-64. PubMed ID: 1978981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blocking agents and positive inotropic agents in the therapy of chronic heart failure.
    Erdmann E; Schwinger R; Böhm M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S138-44. PubMed ID: 11527118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New positive inotropic drugs in acute and chronic heart failure].
    Follath F
    Schweiz Rundsch Med Prax; 1992 May; 81(21):704-7. PubMed ID: 1351309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the beta adrenoceptor subtype(s) mediating the positive inotropic effects of epinine, dopamine, dobutamine, denopamine and xamoterol in isolated human right atrium.
    Deighton NM; Motomura S; Bals S; Zerkowski HR; Brodde OE
    J Pharmacol Exp Ther; 1992 Aug; 262(2):532-8. PubMed ID: 1354251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacology of inodilators.
    Dei Cas L; Metra M; Visioli O
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S60-71. PubMed ID: 2483442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1.
    Colucci WS; Wright RF; Braunwald E
    N Engl J Med; 1986 Jan; 314(5):290-9. PubMed ID: 2867470
    [No Abstract]   [Full Text] [Related]  

  • 20. Present and future trends in research and clinical applications of inodilators.
    Cargnelli G; Piovan D; Bova S; Padrini R; Ferrari M
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S124-32. PubMed ID: 2483438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.